Study Focuses on Adolescent Data in Upadacitinib AD Trials ...Middle East

Medscape - News
The JAK inhibitor was generally well tolerated among the adolescents, with mild or moderate acne being the most common adverse event, the authors reported. MDedge News

Read More Details
Finally We wish PressBee provided you with enough information of ( Study Focuses on Adolescent Data in Upadacitinib AD Trials )

Apple Storegoogle play

Also on site :



Latest News